{"id":"W4400247649","doi":"10.1002/cam4.7415","title":"Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018)","year":2024,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Lenvatinib; Medicine; Sorafenib; Internal medicine; Hepatocellular carcinoma; Bevacizumab; Atezolizumab; Progression-free survival; Oncology; Overall survival; Gastroenterology; Cancer; Nivolumab; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005359654,0.0003648305,0.0007789832,0.0002700195,0.0001045523,0.00002631251,0.0002424197,0.0001054296,0.0005248052],"category_scores_gemma":[0.00007187618,0.0001774222,0.0001294697,0.0008540103,0.0002432033,0.00006873028,0.00004158199,0.00035919,0.00002334468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001473819,"about_ca_system_score_gemma":0.0001446566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003397614,"about_ca_topic_score_gemma":0.0001878246,"domain_scores_codex":[0.9977982,0.0001730701,0.0006243293,0.0004501985,0.0005592181,0.0003949891],"domain_scores_gemma":[0.9986805,0.0003247639,0.00009931844,0.0006244686,0.0001247586,0.0001461436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002815626,0.0001461713,0.9605644,0.0001452173,0.000248851,0.0001218566,0.007000573,6.950448e-7,0.0007927323,0.00004927488,0.008886714,0.02176191],"study_design_scores_gemma":[0.00487926,0.0009200219,0.9545261,0.0005793717,0.0003911127,0.00001515053,0.0005485304,0.001444449,0.001350944,0.00003443572,0.03510606,0.0002046226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9463891,0.02935467,0.00002034254,0.021268,0.0004940851,0.001841686,0.00006316979,0.0000372768,0.0005316203],"genre_scores_gemma":[0.9955277,0.00107319,0.00004425042,0.001956983,0.0003200093,0.0003869874,0.0001443663,0.00004915435,0.0004973513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04913855,"threshold_uncertainty_score":0.7235069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05650383963329626,"score_gpt":0.2865017736609094,"score_spread":0.2299979340276131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}